Monodar

Monodar: Ukrainian short-acting insulin

Monodar is a drug that is produced in Ukraine and belongs to the group of short-acting insulins. It is used to treat diabetic patients to lower blood sugar levels after meals. Let's take a closer look at this drug.

Manufacturer country

Monodar is produced in Ukraine, where the company Indar CJSC specializes in the production of insulin. Ukraine has extensive experience in insulin production and is the largest insulin producer in Eastern Europe.

Farm group

Monodar belongs to the group of short-acting insulins. These drugs are quickly absorbed by the body and quickly lower blood sugar levels. Short-acting insulins are usually taken before meals to compensate for the increase in blood sugar caused by meals.

Manufacturers

As already mentioned, Monodar is produced by Indar CJSC in Ukraine. The company specializes in the production of insulin and produces a wide range of different types of insulin.

International name and synonyms

The international name of Monodar is Insulin-BD. This drug is also known by many synonyms, including Berlinsulin N Normal U-40, Berlinsulin N Normal pen, Biogulin Regular U-100, Biogulin Regular U-40, Biosulin N, Brinsulrapi MK, Brinsulrapi H, Insulin, Insulin "M", Insulin Actrapid, Insulin Actrapid MK, Insulin Actrapid MS, Insulin Iletin II Regular and others.

Dosage forms

Monodar is available in the form of an injection solution of 40 units/ml. It comes in 5 ml glass bottles.

Conclusion

Monodar is a Ukrainian short-acting insulin produced by Indar CJSC. This drug quickly lowers blood sugar and is used to treat diabetes. It is available as an injection solution of 40 units/ml and has many synonyms.